Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1653 1657
This examiner grants 42% of resolved cases
Paul C. Martin has resolved 827 cases in Art Unit 1653 of Tech Center 1600. His allowance rate is 41.8 percent. This percentage is a primary metric for practitioners to consider when evaluating the examiner's history. The data also shows an interview lift of 21.6 percent. This 21.6 percent lift indicates the change in allowance probability associated with an interview.
The median days to allowance is 1228. This 1228-day figure represents the duration of the prosecution process for cases that reach a grant. Practitioners should consider the 827 resolved cases as a historical record of the examiner's work. The 41.8 percent allowance rate and 21.6 percent interview lift are components of the examination profile. The median pendency is a factor for managing client expectations.
Direct communication is a documented tactic, as shown by the lift. Applicants should review the allowance rate as they prepare their prosecution strategy. The cases provide a data set for understanding the examiner's approach in Tech Center 1600. The timeline is a measure of the time required to navigate Art Unit 1653 to a successful conclusion.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18811838 | Enzymatic and Acid Methods for Individualizing Trichomes | Non-Final OA | The Procter & Gamble Company |
| 18027821 | METHOD OF APPLYING FORCE TO ORGANISM AND DEVICE FOR APPLYING FORCE TO ORGANISM | Final Rejection | NIKON CORPORATION |
| 17778765 | IMMUNOMAGNETIC SEQUENTIAL ULTRAFILTRATION PLATFORM FOR ENRICHMENT AND PURIFICATION OF EXTRACELLULAR VESICLES FROM BIOFLUIDS | Final Rejection | OHIO STATE INNOVATION FOUNDATION |
| 17613994 | CELL STORAGE AND TRANSPORTATION MEDIUM, SYSTEM, AND METHOD OF CELL AGGREGATES | Non-Final OA | CORNING INCORPORATED |
| 18560940 | METHOD AND APPARATUS FOR IMAGING A BIOLOGICAL SAMPLE | Non-Final OA | LEICA MICROSYSTEMS CMS GMBH |
| 17616427 | IMAGING SAMPLE FOR MASS SPECTROMETER AND METHOD FOR PRODUCING SAME | Non-Final OA | ASAHI KASEI KABUSHIKI KAISHA |
| 16515458 | HIGHLY MULTIPLEXED AND MASS SPECTROMETRY BASED METHODS TO MEASURING 72 HUMAN PROTEINS | Non-Final OA | Cedars-Sinai Medical Center |
| 17669059 | THREE-DIMENSIONAL POROUS HYBRID SCAFFOLD AND MANUFACTURE THEREOF | Non-Final OA | NANYANG TECHNOLOGICAL UNIVERSITY |
| 18743999 | LIGHT ASSISTED DRYING METHODS, DEVICES, AND SYSTEMS FOR THE PREPARATION OF BIOLOGICS FOR PRESERVATION AND STORAGE | Non-Final OA | THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE |
| 17909067 | COMPOSITION FOR EXTENDING VIABLE PRESERVATION AND SHELF-LIFE OF ORGANS AND TISSUES | Non-Final OA | University of Notre Dame du Lac |
| 18739113 | UFMYLATION INHIBITION TO TARGET TAUOPATHY IN HUMAN NEURONS | Non-Final OA | Cornell University |
| 16885331 | CONDITIONING PROTOCOLS AND USE OF SAME FOR TISSUE REGENERATION | Final Rejection | Yeda Research and Development Co. Ltd. |
| 16091641 | Method for Determining Stage of Periodontal Disease | Final Rejection | ARKRAY, Inc. |
| 18045126 | DECELLULARIZED VASCULAR GRAFTS, METHODS, AND BENCH-TOP MODELS OF ATHEROSCLEROSIS | Final Rejection | Wayne State University |
| 18181023 | OPTIMIZATION OF FLUID POOLING | Final Rejection | Fenwal, Inc. |
| 18902290 | METHODS OF ADMINISTERING COMPOSITIONS OF BACILLUS SUBTILIS PB6, BUTYRIC ACID WITH ZINC, AND OPTIONALLY RED CLOVER, TO REDUCE LIVER ABSCESSES IN CATTLE | Non-Final OA | KEMIN INDUSTRIES, INC. |
| 18286405 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | Non-Final OA | THE CHILDREN'S MEDICAL CENTER CORPORATION |
| 18276912 | METHOD FOR PRODUCING THREE-DIMENSIONAL TISSUE BODY AND METHOD FOR PROMOTING DIFFERENTIATION OF ADIPOSE-DERIVED STEM CELLS | Final Rejection | Kyoto Prefectural Public University Corporation |
| 18547760 | NONAUTOLOGOUS MULTI-STRESSED CANCER CELLS AND USES THEREOF FOR VACCINATING AND TREATING CANCERS | Non-Final OA | BRENUS PHARMA |
| 18262433 | METHOD OF CHANGING CULTURE MEDIUM OF A CULTURE USING SPINFILTERS | Final Rejection | REPAIRON GMBH |
| 16493565 | Device, Method, And System For Identifying Organisms And Determining Their Sensitivity To Toxic Substances Using The Changes In The Concentrations Of Metabolites Present In Growth Medium | Final Rejection | Ian LEWIS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy